Skip to Content

Sinovac Biotech Ltd SVA

Morningstar Rating
Unlock our analysis with Morningstar Investor

About Quantitative Ratings

Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.

Price vs Fair Value

SVA is trading at a 7% discount.
Price
$6.47
Fair Value
$4.28
Uncertainty
Very High
1-Star Price
$58.79
5-Star Price
$2.49
Economic Moat
Gcgqc
Capital Allocation
Is it the right time to buy, sell, or hold?
Start a free trial of Morningstar Investor to unlock exclusive ratings and continuous analyst coverage to help you decide if SVA is a good fit for your portfolio.

News

Trading Information

Previous Close Price
Day Range
52-Week Range
Bid/Ask
/
Market Cap
Volume/Avg
/

Key Statistics

Price/Earnings (Normalized)
23.52
Price/Sales
1.83
Dividend Yield (Trailing)
Dividend Yield (Forward)
Total Yield

Company Profile

Sinovac Biotech Ltd is a biopharmaceutical company. The company focuses on the research, development, manufacturing, and commercialization of vaccines for infectious diseases. Its product portfolio includes vaccines against hepatitis A and B, seasonal influenza, H5N1 pandemic influenza (avian flu), H1N1 influenza (swine flu), mumps, and canine rabies. The company also provides services for disease control and prevention, collaborating with the Chinese governments at the national, state, and local levels. It sells its vaccines in China, while also exploring growth opportunities in international markets.
Sector
Healthcare
Industry
Biotechnology
Stock Style Box
Small Growth
Total Number of Employees
4,275

Comparables

Valuation

Metric
SVA
01099
06185
Price/Earnings (Normalized)
23.526.88
Price/Book Value
1.820.890.71
Price/Sales
1.830.107.90
Price/Cash Flow
8.10
Price/Earnings
SVA
01099
06185

Financial Strength

Metric
SVA
01099
06185
Quick Ratio
9.731.062.03
Current Ratio
9.891.342.24
Interest Coverage
−1,215.786.60−33.97
Quick Ratio
SVA
01099
06185

Profitability

Metric
SVA
01099
06185
Return on Assets (Normalized)
−5.54%3.76%−15.86%
Return on Equity (Normalized)
−8.78%21.58%−26.66%
Return on Invested Capital (Normalized)
−6.80%7.90%−19.21%
Return on Assets
SVA
01099
06185
See how this stock stacks up to its competitors with Morningstar Investor

Biotechnology Industry Comparables

Ticker
Name
Morningstar Rating for Stocks
Economic Moat
Market Cap
NVO
Novo Nordisk A/S ADRRzvf$541.7 Bil
VRTX
Vertex Pharmaceuticals IncZzqvkbg$111.3 Bil
REGN
Regeneron Pharmaceuticals IncPqmrv$109.0 Bil
MRNA
Moderna IncYwzw$36.8 Bil
ARGX
argenx SE ADRYcnm$24.3 Bil
BNTX
BioNTech SE ADRQyrhw$22.1 Bil
ALNY
Alnylam Pharmaceuticals IncGgypwrz$20.0 Bil
BMRN
Biomarin Pharmaceutical IncQnljb$17.1 Bil
RPRX
Royalty Pharma PLC Class ACxgcbkr$14.0 Bil
INCY
Incyte CorpRnxwlv$13.7 Bil

Sponsor Center